borderline significantp = 0.05
In contrast, HbA1c level was supported by moderate-certainty evidence, with a borderline significant reduction (MD: −0.17; p = 0.05) and acceptable heterogeneity (I 2 = 44%).
In contrast, HbA1c level was supported by moderate-certainty evidence, with a borderline significant reduction (MD: −0.17; p = 0.05) and acceptable heterogeneity (I 2 = 44%).
The overall pooled mean difference across all the studies was −1.79 (95% CI: −3.70 to 0.13; p = 0.07), suggesting a trend toward significance in favor of the experimental treatment.